4//SEC Filing
Jolly Mohanjit 4
Accession 0001213900-25-112277
CIK 0001427570other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:45 PM ET
Size
6.3 KB
Accession
0001213900-25-112277
Insider Transaction Report
Form 4
Jolly Mohanjit
Director
Transactions
- Award
Common Stock
2025-08-15+454,456→ 454,456 total(indirect: See footnote)
Footnotes (2)
- [F1]Under the terms of the Agreement and Plan of Merger, dated as of July 8, 2024, as amended (the "Merger Agreement"), by and among the Issuer, Raider Lifesciences Inc., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Vyome Therapeutics, Inc. ("Vyome Therapeutics"), on August 15, 2025, Merger Sub merged with and into Vyome Therapeutics, with Vyome Therapeutics surviving the merger as a subsidiary of the Issuer (the "Merger"). Upon the closing of the Merger, each share of common and preferred stock of Vyome Therapeutics, was converted into the right to receive 1 share of the Issuer's common stock for every 5,000 shares of Vyome Therapeutics. As a result of the Merger, the Issuer was renamed "Vyome Holdings, Inc." and Vyome Therapeutics continued under its name as Vyome Therapeutics, Inc. The reporting person received 454,456 shares of the Issuer's common stock in exchange for 2,272,280,000 shares of common stock of Vyome Therapeutics pursuant to the Merger Agreement.
- [F2]Includes indirect beneficial ownership of 454,456 shares of common stock held by Iron Pillar Fund I Ltd. Mohanjit Jolly is a general partner of Iron Pillar Fund I Ltd. and an advisor to and representative of Iron Pillar India Fund I for investments in the Issuer.
Documents
Issuer
Vyome Holdings, Inc
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001867575
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:45 PM ET
- Size
- 6.3 KB